NEI sets stage for new clinical trial to tackle dry eye
For some people it feels like a speck of sand in the eye, or stinging or burning that doesn’t go away. For others, dry eye disease (or simply dry eye) can become a chronic condition that leads to blurred vision or even vision loss if it goes untreated. (Source: News from NEI)
Source: News from NEI - September 29, 2014 Category: Opthalmology Authors: Jason Source Type: news

National Eye Institute's Wistow Receives Cogan Award
Graeme Wistow, Ph.D., a researcher at the National Eye Institute (NEI), one of the Federal government’s National Institutes of Health, has been selected by the Association for Research in Vision and Ophthalmology (ARVO) to receive its prestigious Cogan Award for outstanding contributions to visual science. Language English (Source: News from NEI)
Source: News from NEI - August 29, 2014 Category: Opthalmology Authors: David Source Type: news

Health Education Leads to More Eye Exams in Group at Risk for Vision Loss
Researchers at Teachers College, Columbia University and Albert Einstein College of Medicine have determined that health education programs can substantially increase the rates of dilated eye exams for African Americans with diabetes, the first step in reducing the risk of vision loss. The results were published in the December 1999 issue of the American Journal of Public Health. Language English (Source: News from NEI)
Source: News from NEI - August 29, 2014 Category: Opthalmology Authors: David Source Type: news

Treatment for Retinitis Pigmentosa Reported
Most adults with blinding retinitis pigmentosa (RP) should take adaily, 15,000 IU vitamin A supplement, based on results from a large,randomized clinical trial published today in the Archives ofOphthalmology. Language English (Source: News from NEI)
Source: News from NEI - August 29, 2014 Category: Opthalmology Authors: David Source Type: news

Light Reduction Does Not Affect Blinding Eye Disease in Premature Infants
Photos and b-roll available Researchers supported by the National Eye Institute have determined that light reduction has no effect on the development of a potentially blinding eye disorder in low birthweight infants. A paper detailing these findings is published in the May 28, 1998 issue of The New England Journal of Medicine. Language English (Source: News from NEI)
Source: News from NEI - August 29, 2014 Category: Opthalmology Authors: David Source Type: news

Blacks, Whites Benefit from Different Surgical Glaucoma Treatments
Researchers supported by the National Institutes of Health have discovered that black and white patients with advanced glaucoma respond differently to two surgical treatments for the disease. A paper detailing these findings is published in the July 1998 issue of Ophthalmology. Scientists found that blacks with advanced glaucoma benefit more from a regimen that begins with laser surgery, and whites benefit more from one that begins with an operation called a trabeculectomy. Language English (Source: News from NEI)
Source: News from NEI - August 29, 2014 Category: Opthalmology Authors: David Source Type: news

Ten-Year Results on Radial Keratotomy Released
After a decade of patient followup, a National Eye Institute (NEI)-supported study reported today that radial keratotomy (RK) remained a reasonably safe and effective technique to improve distance vision. However, the study found that more than 40 percent of RK-operated eyes continued to have a gradual shift toward farsightedness. This finding suggests that some people who have RK may need glasses at an earlier age for poor close-up vision, a common problem after age 40, than if they had chosen not to have the surgery. Language English (Source: News from NEI)
Source: News from NEI - August 29, 2014 Category: Opthalmology Authors: David Source Type: news

Freeze Treatment Reduces Blindness in Premature Infants
Briefly freezing a portion of the eye’s surface can protect many premature infants against blindness from retinopathy of prematurity (ROP), a disease that causes visual loss in 2,600 infantsin the United States annually. In a National Eye Institute-supportedmulticenter clinical trial, cryotherapy (freeze treatment) reduced therisk of severe visual loss by one-half in 172 babies with advancedROP. Language English (Source: News from NEI)
Source: News from NEI - August 29, 2014 Category: Opthalmology Authors: David Source Type: news

Corticosteroids for First-Time Optic Neuritis Lowers Risk of Developing Multiple Sclerosis
Over half of all people with first-time optic neuritis, a vision-impairing inflammation of the optic nerve, will eventuallydevelop multiple sclerosis (MS). But researchers report today in the New England Journal of Medicine that treating first-time optic neuritis patients with a combination of intravenous and oral corticosteroids lowers their risk of developing MS within the next two years. Language English (Source: News from NEI)
Source: News from NEI - August 29, 2014 Category: Opthalmology Authors: David Source Type: news

Oral Corticosteroids Alone Found Ineffective for Optic Neuritis
Although commonly used, oral corticosteroids alone are ineffective in treating optic neuritis, a debilitating inflammation of the optic nerve, and actually increase a person’s risk for future attacks, according to a large National Eye Institute-supported clinical trial published today in the New England Journal of Medicine. Language English (Source: News from NEI)
Source: News from NEI - August 29, 2014 Category: Opthalmology Authors: David Source Type: news

New Treatment for Eye Disease Reduces Need for Strong Drugs
Researchers at the National Institutes of Health (NIH) have discovered a substance that allows people with uveitis, a potentially blinding eye disease, to stop or reduce the need for powerful drugs. A paper detailing these findings is published in the May 1997 issue of the American Journal of Ophthalmology. Language English (Source: News from NEI)
Source: News from NEI - August 29, 2014 Category: Opthalmology Authors: David Source Type: news

Gene profiling technique to accelerate stem cell therapies for eye diseases
Researchers at the National Institutes of Health have developed a technique that will speed up the production of stem-cell derived tissues. The method simultaneously measures the expression of multiple genes, allowing scientists to quickly characterize cells according to their function and stage of development. The technique will help the researchers in their efforts to use patients' skin cells to regenerate retinal pigment epithelium (RPE)—a tissue in the back of the eye that is affected in several blinding eye diseases. It will also help the scientists search for drugs for personalized treatments. (Source: News from NEI)
Source: News from NEI - July 16, 2014 Category: Opthalmology Source Type: news

Rehabilitation helps prevent depression from age-related vision loss
Depression is a common risk for people who have lost their vision from age-related macular degeneration (AMD), but a new study shows that a type of rehabilitation therapy can cut this risk in half. The study was funded by the National Eye Institute (NEI), part of the National Institutes of Health. (Source: News from NEI)
Source: News from NEI - July 9, 2014 Category: Opthalmology Source Type: news

NIH study reveals gene critical to the early development of cilia
Researchers at the National Eye Institute (NEI) have described the functions of a gene responsible for anchoring cilia - sensory hair-like extensions present on almost every cell of the body. They show in a mouse model that without the gene Cc2d2a, cilia throughout the body failed to grow, and the mice died during the embryonic stage. The finding adds to an expanding body of knowledge about ciliopathies, a class of genetic disorders that result from defects in the structure or function of cilia. NEI is part of the National Institutes of Health. (Source: News from NEI)
Source: News from NEI - July 3, 2014 Category: Opthalmology Source Type: news